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Abstract
Jacobsen syndrome (11q-) is a rare chromosomal disorder characterized by
multiple problems including congenital heart defects, behavioral problems,
intellectual disability, dysmorphic features, and bleeding problems. Septal
defects, including double outlet right ventricle (DORV), are among the most
common CHDs that occur in 11q-. One possible mechanism underlying the
CHDs and other problems in 11q- is a defect in neural crest cell function. The
E26 avian leukemia 1, 50 domain (ETS-1) gene is a member of the ETS-domain
transcription factor family. ETS-1 is deleted in every 11q- patient with CHDs,
and gene-targeted deletion of the ETS-1 gene in C57/B6 mice causes DORV
with 100 % penetrance. Normal murine cardiac development requires precisely
regulated specification of the cardiac neural crest cells (cNCCs). To begin to
define the role of ETS-1 in mammalian cardiac development, we have
demonstrated that ETS-1 is strongly expressed in mouse cNCCs during early
heart development. Sox10 is a key regulator for the neural crest cell gene
regulatory network. It is also an early marker for NCCs, and its expression can
facilitate the analysis of cNCC function during embryonic development. We
have demonstrated that loss of ETS-1 causes decreased migrating Sox10-
expressing cells in E10.5 C57/B6 mouse embryos. These results suggest a
NCC migration defect in ETS-1 mutants. Our data support the hypothesis that
ETS-1 is required for specification and migration of cNCCs and for regulating a
cNCC-specific gene regulatory network that is required for normal cardiac
development.
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52.1 Introduction
Congenital heart defects (CHDs) are the most common birth defect in live-born
infants, occurring in 0.7 % of the general population. Although there are numerous
genetically engineered mouse models for CHDs, only a small number of these
genes are currently associated with CHDs in humans.
Conotruncal defects (CTDs), including double outlet right ventricle (DORV),
are among the most common CHDs in the general population and usually require
surgical repair to ensure a normal life expectancy. Little is known about the
molecular and cellular mechanisms underlying the development of CTDs in
humans. Normal murine cardiac development requires precisely regulated specifi-
cation of the cardiac neural crest cells (cNCCs) and subsequent migration to the
developing outflow tract. In animal models, impairment of NCCs causes CTDs [1].
The 11q terminal deletion disorder (11q-, Jacobsen syndrome) (OMIM #
1477910) is caused by heterozygous deletions in distal 11q (Fig. 52.1).
Fifty-six percent of patients have CHDs (Table 52.1). Septal defects, including
DORV, account for about half of all CHDs that occur in 11q- patients.
As shown in Fig. 52.2, we have identified a Jacobsen syndrome cardiac “critical”
region in distal 11q containing only five known genes, including the ETS-1
transcription factor.
The ETS-1 gene is a member of the ETS-domain transcription factor family.
ETS factors have important roles in a host of biological functions, including the
regulation of cellular growth and differentiation as well as organ development.
Fig. 52.1 Patient with Jacobsen syndrome. Karyotype demonstrates large terminal deletion
in 11q
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Until recently, nothing was known about the function of ETS-1 in mammalian heart
development or its possible role in causing human congenital heart disease.
Although little is known about the mechanisms underlying ETS-1 in mammalian
heart development, recent studies in the ascidian Ciona intestinalis have
demonstrated that ETS-1 regulates two critical aspects of heart development:
heart progenitor cell migration and heart cell differentiation. Interestingly, loss of
ETS-1 abolishes normal heart cell migration during development, resulting in an
ectopically located heart chamber. Taken together, these results indicate that ETS-1
Table 52.1 CHDs in 11q- Left-sided/flow lesions (two-thirds)







Less common heart defects (one-third)
Secundum atrial septal defect
Aberrant right subclavian artery
Atrioventricular septal canal defect
D-transposition of the great arteries
Dextrocardia
Left-sided superior vena cava
Tricuspid atresia
Type B interruption of the aortic arch/truncus arteriosus




a~10 % born with HLHS; ~1–2 % of all HLHS pts






















Fig. 52.2 Cardiac “critical” region in 11q, defined by region of overlap between smallest terminal
deletion and interstitial deletions in patients with Jacobsen syndrome clinical phenotype, including
congenital heart defects
52 Evidence That Deletion of ETS-1, a Gene in the Jacobsen Syndrome (11q-). . . 363
is required for normal cell migration in heart development, although the mechanism
(s) underlying these cell migration defects remains to be elucidated.
52.2 Evidence for a Role for ETS-1 in the Cardiac Neural Crest
in Mice
52.2.1 Expression of ETS-1 in Cardiac Lineages During Murine Heart
Development
To begin to define the role of ETS-1 in mammalian cardiac development, we have
performed in situ hybridization studies on mouse embryos and have shown that
ETS-1 is strongly expressed in murine cNCCs as well as the endocardium during
early heart development (Fig. 52.3).
52.2.2 ETS-1 Mutant Mice Have a Double Outlet Right Ventricle
(DORV) Phenotype
To determine if loss of ETS-1 causes congenital heart defects, we have analyzed
gene-targeted ETS-1 deletion mice. As shown in Fig. 52.4, ETS-1 homozygous null
mice in a C57/B6 background exhibit DORV with 100 % penetrance, resulting in
perinatal lethality [2].
52.2.3 Lost of ETS-1 Causes Decreased Expression of Sox10
We have previously demonstrated that ETS-1 expression is expressed in cNCCs
and endocardium during murine embryonic development. Sox10 is a key regulator
in the NCC gene regulatory network. It is critical for migration and specification of
NCC fate. To examine the role of ETS-1 in murine cardiac NCC migration, we
examined Sox10 expression in ETS-1/ mutant and control C57/B6 embryos at
E10.5 by using whole-mount in situ hybridization analysis. Expression of Sox10 in
the NCCs in the pharyngeal arch region and dorsal root ganglia was reduced in
ETS-1/ mutant embryos, suggestive of a cNCC migration defect as shown in
Fig. 52.5 (left). The result was confirmed independently by quantitative RT-PCR
analysis (right).
52.3 Establishment of an Explanted cNCC “Ex Vivo” Culture
System
We hypothesized that defects in cNCCs migration should be able to be reproduced
in an “ex vivo” culture system. Toward that end, we have utilized an explanted
culture system to observe cNCCmigration [3]. Mouse embryos were collected from
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C57/B6 background embryos at E8.5, coinciding with the onset of cNCC migration
toward the heart. E8.5 embryos were collected and treated by dispase to dissociate
the tissue gently. After treatment, neural tubes from somite one to three region
(cardiac neural crest) were dissected out and cut into 100 300 um pieces. Each
Fig. 52.3 Expression of ETS-1 in the heart in ED9.5 embryos: in situ hybridizations are shown in
(a) (whole mount) and in sections (b) (anterior coronal section) and (c) (posterior coronal section).
Immunohistochemistry indicating endothelial expression using a PECAM (CD31) antibody is
shown in (d) (whole mount) and in sections (e) (anterior coronal) and (f) (posterior coronal). LacZ
staining of neural crest using a Wnt1-Cre; ROSA26 LacZ indicator strain is shown in (g) (whole
mount), (h) (anterior coronal), and (i) (posterior coronal)
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Fig. 52.4 Gene-targeted knockout of ETS-1 in C57/B6 E16.5 mice, showing double outlet right
ventricle with normally related great arteries. Wild type is shown in (a) and (b); two mutant hearts
are shown in panels (c–f). RA right atrium, LA left atrium, RV right ventricle, LV left ventricle, Pu
pulmonary artery, Ao aorta, VSD ventricular septal defect
Fig. 52.5 Whole mount study demonstrating decreased Sox10 expression in E10.5 ETS-1/
C57/B6 embryos (left, lower panel) compared to wild type (left, upper panel). Real-time quantita-
tive PCR demonstrates decreased Sox10 expression in the body of E10.5 embryos in ETS-1/
embryos, compared to wild type (right)
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piece was placed on fibronectin-coated glass bottom slides and incubated in culture
media in 5 % CO2 and 21 % O2. After 24 h incubation, we performed DAPI staining
and obtained images of the migrating cells. Representative results from WT and
ETS-1/ mice are shown in Fig. 52.6.
52.3.1 Loss of ETS-1 in C57/B6Mice Causes Decreased NCC Numbers
and Decreased Migration
To analyze the migration distance using our ex vivo system, we counted the number
of migrating cells in each explanted culture. The migration distance was divided
into three distanced from the neural tube edge: 0–150 μm, 150–300 μm, and over
300 μm edge. The total number of cells that had migrated for each distance was
manually counted, and the percentage of the total for each migration distance was
determined. As shown in Fig. 52.6, cNCCs from ETS-1/ C57/B6 embryos were
fewer in number and had decreased migration distance. The percentage of total cells
migrating >300 μm 24 h after explantation in ETS-1/ mutant embryos is
fourfold lower than control. The cell number per embryo was also significantly
decreased in ETS-1/ mutants.
Fig. 52.6 Cardiac neural crest cells migration in explant culture. (A) Schematic of E8.5 embryo.
Blue bar shows the neural tubes somite one to three region. H heart, NT neural tube. (B)
Representative images with DAPI staining of 24 h cultured cardiac neural crest cells in control
(B) and ETS-1/ mutants (C). Scale bar, 300 μm. Both images were taken by an inverted
confocal microscope FV-1000 using a 10 objective lens. (D) Quantification of migration
distances, demonstrating impaired migration ability in ETS-1/ cells compared to wild type
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We then calculated the ratio of 300+ μm over 0–150 μm of cultured migration
cells. As shown in Fig. 52.6, the ratio was significantly reduced in ETS-1/
mutants.
52.4 Cardiac Neural Crest Cell Number and Migration Are
Preserved in ETS-1/ Mice in an FVBN-1 Background
The cardiac phenotype in ETS-1 knockout mice is dependent on the genetic
background. In contrast to C57/B6 mice, ETS-1/ mutant mice in an FVBN-1
background have normal hearts. Consistent with a neural crest cell autonomous
mechanism for causing DORV in the C57/B6 strain, ex vivo studies demonstrate
normal cNCC numbers and migration in ETS-1/ FVBN-1 embryos (data not
shown).
52.5 Summary, Future Directions, and Clinical Implications
Using human and murine genetics systems, we have identified the ETS-1 transcrip-
tion factor gene as the likely causative gene for CHDs in Jacobsen syndrome. Our
expression data implicate an important role for ETS-1 in the cardiac neural crest
during murine heart development. Based on the known function of the ETS-1
homologue in the ascidian Ciona intestinalis and using an ex vivo cell migration
system, we hypothesize that ETS-1 is essential for early cNCC fate determination
and migration in mammalian heart development. Future studies will include
performing in vivo real-time imaging and lineage fate mapping studies in the neural
crest to delineate how loss of ETS-1 causes decreased cNCCs in the developing
heart [4], whether there is a NCC-autonomous mechanism and whether there is a
migration defect. Importantly, loss of ETS-1 in FVBN-1 mice does not cause
congenital heart defects, suggesting the presence of a genetic modifier(s) that can
prevent the development of CHDs in the absence of ETS-1. To address this,
determination of a neural crest cell autonomous mechanism would implicate a
neural crest cell-specific modifier. Identification of such a genetic modifier could
have important implications for the prevention of certain congenital heart defects.
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